Chengwu Xiao
Papers
3
Total Citations
32
H-Index
3
About
Dr. Chengwu Xiao is a pioneering urological surgeon and researcher whose work centers on advancing minimally invasive surgery through novel robotic platforms. His primary research focus is the clinical translation and validation of single-port robotic systems, particularly the SHURUI Robotic Surgical System, which features deformable surgical instruments designed to overcome the spatial constraints of single-incision surgery. Dr. Xiao’s major contributions include leading the first prospective clinical trials demonstrating the feasibility and safety of this purpose-built system for complex urological procedures. His landmark 2024 study on robot-assisted single-port retroperitoneal partial nephrectomy (14 citations) established a new, less invasive approach for kidney tumor resection, while his 2023 work on single-port radical prostatectomy (13 citations) showcased the system’s precision in prostate cancer treatment. Most notably, his 2024 multicenter trial (5 citations) provided the first comprehensive evidence of the SHURUI system’s efficacy across 50 major urological cases, marking a significant step toward broader clinical adoption. With a growing citation impact, Dr. Xiao is recognized as a key figure in the next generation of robotic surgery, pushing the boundaries of what is possible in urological care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3